Trial Profile
Early Clinical Experiences with Belimumab in Polish Patients with Systemic Lupus Erythematosus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2015
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 02 Sep 2015 New trial record